InvestorsHub Logo
Followers 46
Posts 3422
Boards Moderated 0
Alias Born 10/15/2013

Re: None

Wednesday, 09/02/2020 9:05:12 AM

Wednesday, September 02, 2020 9:05:12 AM

Post# of 3516
Separately, the Company reported that full regulatory approval has been received from Romanian regulatory authorities to begin enrollment in its 24-patient, open label lead-in Phase 1b clinical trial in hospitalized COVID-19 patients at the Romanian National Institute of Infectious Diseases (NIID).
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DFFN News